Warsaw, Poland

Janina Piechaczek

This inventor holds 1 USPTO granted patent. Top assignee: Institut Farmaceutyczny. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janina Piechaczek. Retrieved from https://idiyas.com/inventor/janina-piechaczek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Janina Piechaczek: Innovator in Pharmaceutical Chemistry

Introduction

Janina Piechaczek is a notable inventor based in Warszawa, Poland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for preparing olanzapine polymorphic forms. Her work is essential in advancing the pharmaceutical industry and improving medication efficacy.

Latest Patents

Janina Piechaczek holds a patent for "Methods for preparation of olanzapine polymorphic form I." This invention relates to innovative methods for preparing olanzapine polymorphic Form I. Additionally, it introduces new mixed solvates of olanzapine, which serve as valuable intermediates in the preparation of pure olanzapine polymorphic Form I. This patent highlights her expertise and dedication to enhancing pharmaceutical formulations.

Career Highlights

Janina Piechaczek is affiliated with the Institut Farmaceutyczny, where she applies her knowledge and skills in pharmaceutical research. Her work at this institution has allowed her to focus on developing new methods and improving existing processes in drug formulation.

Collaborations

Janina has collaborated with several talented individuals in her field, including Magdalena Glice and Urszula Fraczek. These collaborations have contributed to her innovative research and the successful development of her patented methods.

Conclusion

Janina Piechaczek is a pioneering inventor whose work in pharmaceutical chemistry has made a significant impact on the industry. Her dedication to innovation and collaboration continues to drive advancements in medication development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…